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Development Center Gene rearrangements are tightly regulated during lym-
²Laboratory of Molecular Immunoregulation phocyte development. Ig genes are fully rearranged and
National Cancer Institute expressed exclusively in B lymphocytes and TCR genes
Frederick, Maryland 21702 only in T lymphocytes, even though they appear to use
the same VDJ recombinase. Furthermore, within each
lymphoid lineage, the loci and the gene segments in
Interleukin-7 (IL-7) is required for normal lymphoid each locus rearrange in a particular order: IgH precedes
development. The rearrangement of receptor genes is Igk and Igl; TCRb generally precedes TCRa; and within
induced in lymphoid progenitors during their period of the IgH and TCRb loci, D±J precedes V±DJ joining
IL-7 dependency. The question addressed in this review (Lewis, 1994).
is: to what extent does IL-7 control the gene rearrange- To explain how certain types of genes are selected
ment process? There are two principal types of controls for rearrangement, it has been postulated that Ig gene
considered. The first is the ``trophic'' effect: IL-7 main- segments are accessible to the recombination machin-
tains the viability of cells during gene rearrangement, ery only in B cells, and TCR segments only in T cells
whereas the signal to induce gene rearrangements may (Yancopoulos et al., 1986). Similarly, the orderly re-
be distinct from IL-7. The second possible control is arrangement of Ig and TCR genes within each lineage
``mechanistic'': IL-7 delivers signals to induce gene re- would be regulated by a differential accessibility of the
arrangement as well as maintains cell viability. This re- genes during lymphocyte precursor development.
view covers current thought on how gene rearrangement In a number of different systems, transcriptionof unre-
is regulated and evaluates recent evidence for a mecha- arranged genes has been observed prior to or concomi-
nistic action of the IL-7 receptor in gene rearrangement. tant with their rearrangement (Blackwell et al., 1986;
Fondell and Marcu, 1992; Schlissel and Baltimore, 1989;
Mechanism of VDJ Recombination CandeÂ ias et al., 1994). It was thus proposed that germ-
The antigen receptors on T and B cells are heterodimers, line transcription of Ig or TCR genes could mediate a
each subunit composed of a variable and a constant local opening of chromatin structure, allowing Ig or TCR
domain. Generation of a diverse repertoire of variable genes to become accessible to the VDJ recombinase.
regions is crucial for the organism to mount a response Transcriptional enhancers and promoters became prime
against virtually any foreign antigen. This diversity is candidates as regulators of rearrangement accessibility
achieved by VDJ recombination, a site-specific DNA (recently reviewed by Sleckman et al., 1996). Each rear-
recombination process unique to early B and T lympho- ranging locus contains at least one transcriptional en-
cytes. hancer. Studies using transgenic miniloci have shown
The gene segments coding for immunolglobulin (Ig) the requirement for specific Ig or TCR enhancers in gene
and T cell receptor (TCR) subunits are grouped in six rearrangment (Ferrier et al., 1990; Capone et al., 1993;
distinct loci. The exons coding for Ig and TCR variable Lauzurica and Krangel, 1994b). Enhancer replacement
domains are formed by the juxtaposition of two (V and or elimination in vivo by homologous recombination ab-
J, for Igk and Igl and for TCRa and TCRg) or three (V, rogates or severely impairs rearrangement at the tar-
D, and J, for IgH and TCRb and TCRd) gene segments. geted loci (Chen et al., 1993; Serwe et al., 1993; Takeda
This rearrangement requires the activity of two lym- et al., 1993; Bories et al., 1996; Bouvier et al., 1996).
phoid-specific proteins, RAG-1 and RAG-2, which However, in some experiments, transcription was in-
achieve the cleavage of DNA (McBlane et al., 1995; van sufficient to promote VDJ recombination (CandeÂ ias et
Gent et al., 1996); endonuclease and terminal deoxy- al., 1994; Okada et al., 1994), and VDJ recombination
nucleotidyl transferase that modify the ends before liga- also was observed in the absence of transcriptional en-
tion (Lewis, 1994; CandeÂ ias et al., 1996); and at least hancers (Lauzurica and Krangel, 1994a) or even in the
four ubiquitously expressed proteins involved in DNA absence of transcription of the rearranging Vb genes
repair (Lewis, 1994; Weaver, 1995). Numerous experi- (Alvarez et al., 1995). Thus, it seems that susceptibility of
ments using transgenic and knockout mice have shown Ig or TCR genes to VDJ recombination does not require
that antigen receptor gene rearrangement and expres- transcription per se. Rather, enhancers may control re-
sion are absolutely required for lymphocyte differentia- modelling of chromatin, rendering the gene accessible
tion. Thus, mice in which RAG-1 or RAG-2 genes have both to the transcriptional apparatus and to VDJ recom-
been deleted show a complete block of both early T binase. The m enhancer, which has been shown to in-
crease the accessibility of neighboring chromatin, is
much aided by matrix attachment regions (MAR) that³Present address: DeÂ partement de Biologie Moleculaire et Structur-
flank the core enhancer, resulting in considerable exten-ale, Laboratoire d'Immunochimie, INSERM, U238, UniversiteÂ Joseph
sion of the regions of chromatin accessibility (JenuweinFourier, Commissariat aÁ l'Energie Atomique de Grenoble (CEA),
CEA-Grenoble, France. et al., 1997). This MAR-induced increase in accessibility
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correlated with extended demethylation of the genes. if it uses a different chain, then it could have activities
distinct from those of IL-7. In support of a novel secondPerhaps the mechanism of specific enhancer or MAR
proteins is through recruitment of chromatin remodeling chain for the TSLP receptor, the precursor T and B cell
phenotypes ingc knockout mice resemble the milder IL-7factors that participate in transcription and facilitate re-
combination. A locus control region has been invoked knockout, rather than the more severe IL-7a knockout.
Signal transduction from the cytokine receptors thatin rearrangement of the TCRa/b locus (Diaz et al., 1994).
The T early a gene appears to facilitate rearrangement share gc include activation of Jak3, which is bound to gc,
and phosphorylation of the insulin receptor substratesof neighboring Ja elements (Villay et al., 1996). There is
also evidence for negative cis-acting elements that (Johnston et al., 1995). Knockouts of gc (Cao et al., 1995;
diSanto et al., 1995) or Jak3 (Nosaka et al., 1995; Parkcould inhibit rearrangement by preventing access to the
recombinase (Lauster et al., 1993). et al., 1995; Thomis et al.,1995) have overlapping pheno-
types with IL-7 and IL-7Ra mutant mice. However, it
remains to be shown whether all IL-7Ra activities de-Role of the Thymus and Bone
pend on gc and Jak3; IL-7Ra may engage unique signalMarrow Microenvironments
transduction pathways that arenot shared with the otherThe rearrangement of TCR genes and subsequent T cell
cytokine receptors that share the gc chain.maturation occurs primarily in the thymus. This organ
What is the role of IL-7Ra in lymphopoiesis? Earlyis composed of an intricate network of different types
lymphoid precursors, in both T and B lineages in mice,of epithelial cells that can be distinguished by surface
are severely depleted in the absence of IL-7Ra signals.markers and anatomical location (van Ewijk, 1991; Boyd
The critical periods thought to be IL-7Ra dependent areet al., 1993). The greater efficiency of T lymphopoiesis
illustrated in Figure 1. Although the indicated precursorin this organ than elsewhere is presumably based on
stages are undetectable in these mutant mice, somecell surface structures and locally acting cytokines, most
cells manage to transit (or bypass) these stages in theof which remain to be identified. A recent report impli-
absence of IL-7R signaling, mature, and accumulate incates the CD81 molecule expressed on thymic epithelial
peripheral lymphoid organs, eventually reaching num-cells in ab, but not gd, T cell development (Boismenu
bers up to 20%of normal (Peschon et al., 1997), althoughet al., 1996). However, CD81 is not exclusively expressed
they are functionally abnormal (Maraskovsky et al.,on thymic epithelium. Many of the known cytokines have
1996). In IL-7R2/2 mice, the gd T cell lineage is the mosteffects on thymocytes; however, analysis of cytokine-
severely depleted mature lymphoid population, beingdeficient mice revealed no absolute requirements for
below the level of detection (He and Malek, 1996; Makithese factors in thymocyte maturation, the only excep-
et al., 1996b), whereas NK cells are not deficient (Hetion so far being IL-7. Murine B cell development in bone
and Malek, 1996). Comparing IL-7R2/2 to IL-72/2 mice,marrow also depends on IL-7 and onstromal cell contact
the gd T cell population is not as severely reduced inproviding largely unknown signals, but including SDF-1
the latter (Moore et al., 1996).(Nagasawa et al., 1996).
During T cell development, the CD251 stages are
missing in IL-7R2/2 mice, and IL-7 certainly promotes
IL-7/Thymic Stroma±Derived Lymphopoietin survival of isolated CD251 cells in vitro. Prior to and
and Lymphoid Development following the CD251 stages, IL-7/TSLP dependency is
IL-7 was discovered based on its ability to stimulate not exactly clear. It could begin even before thymic
mouse B lymphoid development in vitro (Namen et al., entry; for example, much earlier hematopoietic stages
1988), but was soon shown to stimulate thymocytes react to IL-7 (Grzegorzewski et al., 1995), and it could
(Conlon et al., 1989; Watson et al., 1989). It is now well extend past the double-negative stage. The thymic epi-
established that normal development of both T and B thelium first produces detectable IL-7 protein at embry-
lymphoid lineages in the mouse depend on IL-7 pro- onic day 13 (Wiles et al., 1992), coinciding with the earli-
duced by stromal cells. Treatment of mice with anti-IL-7 est stages of T cell development. Ectopic expression of
antibodies severely repressed development of both T IL-7 is reported to induce extrathymic T cell develop-
and B cells (Grabstein et al., 1993; Bhatia et al., 1995) ment (Kenai et al., 1993; Rich and Leder, 1995).
as did knockout of IL-7 (von Freeden-Jeffry et al., 1995, B cell development in mice is severely interrupted in
1997). the absence of IL-7Ra signaling. Five stages have been
The IL-7 receptor has two components: the a chain identified in normal mice (Hardy et al., 1991). As shown
(Goodwin et al., 1990), which is a member of the hemato- in Figure 1, only the first stage is found in IL-7Ra2/2
poietin superfamily, and gc, which isshared by the recep- mice (Peschon et al., 1994, 1997). By comparison,
tors for IL-2, IL-4, IL-7, IL-9, and IL-15 (Noguchi et al., IL-72/2 mice arrest at a later stage in B cell development
1993a; Kondo et al., 1994). Knockout of the IL-7Ra gene (Grabstein et al., 1993; von Freeden-Jeffry et al., 1995
showed a 10-fold reduction in peripheral T and B cells and 1997). That IL-7Ra dependency appears earlier than
and a 10- to 10,000-fold reduction in thymocytes IL-7 dependency could be explained if TSLP acted ear-
(Peschon et al., 1994, 1997). This is an even more severe lier. Following successful light chain rearrangement, IL-7
lymphopenia than deletion of IL-7, attributed to the ob- dependency appears to end (Henderson et al., 1992). A
servation that a second cytokine, thymic stroma± transgenic mouse strain overexpressing IL-7 showed a
derived lymphopoietin (TSLP) also binds the IL-7Ra dramatic increase in immature B cells (Fisheret al., 1995;
chain (Friend et al., 1994). The activities and sites of Mertsching et al., 1995).
production of TSLP have not been reported yet. It is not Human B cell development does not appear to require
IL-7 in vitro (Pribyl et al., 1996), and there is no humanclear whether the TSLP receptor also incorporates gc;
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Figure 1. T Cell and B Cell Development
VDJ recombination occurs during IL-7Ra±dependent stages in lymphoid development.
TSLP homolog yet identified that could bypass an IL-7 Of these potential growth stimuli, SCF synergy with
IL-7 has been best characterized. SCF plus IL-7 inducesblock. Patients with human X-linked severe combined
immunodeficiency, who lack functional gc (Noguchi et vigorous cell division of early thymocytes in vitro (Mor-
rissey et al., 1994), and in vivo there is evidence thatal., 1993b), produce normal numbers of B cells, unlike
the mouse gc knockouts (Cao et al., 1995). Thus, human SCF is required for optimal growth in early thymocytes
(Rodewald et al., 1995). SCF is apparently not requiredB cell development is controlled by remarkably different
stimuli than murine, suggesting that another cytokine for B cell development (Takeda et al., 1997). Induction
of phosphatidylinositol-3-kinase has been invoked inreceptor pathway has IL-7R-like activities. This is remi-
niscent of the finding that the cytokine oncostatin M, the trophic effects of IL-7 on early B cells (Corcoran et
al., 1996).which uses neither of the IL-7 receptor chains, may
nevertheless mimick it in that it too can trigger extrathy- A Bcl-2 family member could mediate the IL-7 trophic
effects on lymphoid progenitors. In mature T cell lines,mic T cell development in mice (Clegg et al., 1996).
IL-7 was shown to induce Bcl-2 (Hernandez et al., 1995).
In a lymphoma that is IL-7 dependent, Bcl-2 expressionIL-7 Trophic Effects
Immature thymocytes isolated from the thymus rapidly rapidly declined following IL-7 withdrawal, and anti-
sense bcl-2 blocked the IL-7 survival effect (Lee et al.,undergo apoptotic cell death and IL-7 has a striking
effect in sustaining their survival without notable cell 1996). However, Bcl-2 itself is unlikely to be the sole
mediator of IL-7Ra signaling in early lymphoid cells,division (Watson et al., 1989). There are also trophic
effects of IL-7 on mature lymphoid cells (Komschlies et because bcl-22/2 mice (Veis et al., 1993) produce an
early wave of T cell development (unlike IL-7R2/2 mice),al., 1994). It has sometimes been concluded that IL-7 is
a growth factor; however, in each example there can be and the failure in subsequent waves has been attributed
to a prethymic stage (Matsuzaki et al., 1997). Therefore,identified a second signal which could be interpreted
as the real growth stimulus, with IL-7 performing an anti- another family member, such as Bcl-xL or Bcl-w, or some
other anti-apoptotic mechanism, could partly mediateapoptotic function. The real growth stimuli during the
IL-7 dependent phases could then be, for T cells, stem IL-7R effects. For example, CPP32 enzyme activity was
down-regulated by IL-7 in a lymphoma (Lee et al., 1996),cell factor (SCF) and later the pre-TCR complex (Fehling
et al., 1995), and for B cells, a stromal factor (such as although this could be a downstream effect of Bcl-2
induction in this cell, rather than an independent antia-SDF-1, Nagasawa et al., 1996) and later the pre-Ig com-
plex (Karasuyama et al., 1996). poptotic pathway. IL-3 antiapoptotic mechanisms were
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recently associated with phosphorylation of BAD (Zha IL-7Ra signaling in g rearrangement because it has been
established that the same cell, at about the same time,et al., 1996).
initiates rearrangement of g, b, and d loci, and ab T
cells frequently have rearranged g loci. Therefore, the
IL-7R and VDJ Recombination absence of g rearrangements in IL-7Ra2/2 mice cannot
The following sections consider different Ig and TCR be due to the absence of gd cells; in the same vein,
loci and the role of IL-7Ra signals in their rearrangement. TCRd2/2 mice, which contain only abT cells, have TCRg
The loci are treated separately because it remains possi- rearrangements (CandeÂ ias et al., 1997). Because IL-7Ra
ble that IL-7Ra affects each one differently. is also part of the receptor for TSLP, it is possible that
TCRb Locus TSLP instead of, or in addition to IL-7, is the relevant
This was the first locus whose rearrangement was pro- signal for g gene rearrangement.
posed to be controlled by IL-7. In the initial studies, TCRd Locus
mouse thymocytes, removed at embryonic day 14, un- In studies using the thymic reaggregation system dis-
derwent V±DJ rearrangement in vitro in the presence of cussed above (Oosterwegel et al., 1997), stroma from
IL-7 (Muegge et al., 1993). This approach does not IL-72/2 mice failed to induce d rearrangements. The re-
clearly distinguish a mechanistic from trophic effect of aggregation system had a more stringent requirement
IL-7 on the rearrangement process, although alternative for IL-7 than did intact mice, since IL-7Ra2/2 mice pro-
trophic stimuli, such as IL-2 or phorbol myristate acetate duced thymic d rearrangements in vivo (Maki et al.,
and ionophore, did not support rearrangement. The 1996a;CandeÂ ias et al., 1997). Thus, if IL-7Ra has a mech-
most recent approach (Oosterwegel et al., 1997) evalu- anistic role in rearrangement of the d locus, it is less
ated the ability of thymic stroma from IL-7 knockout stringent than for the g locus.
mice to support b locus rearrangement after reaggrega- IgH Locus
tion with fetal liver lymphocyte precursor cells. b locus An elegant approach has distinguished mechanistic
rearrangement in this system stringently depended on from trophic effects of IL-7Ra in rearrangement of the
IL-7, much more so than it does in vivo in IL-72/2 or IL- IgH locus (Corcoran et al., 1996). B cells failed todevelop
7R2/2 mice, which produce ab T cells, albeit at a very from IL-7Ra2/2 precursors in vitro, but development was
low rate (Peschon et al., 1997; von Freeden-Jeffry et al., restored by providing the missing IL-7Ra chain by
1997). Patients with human X-linked severe combined means of retroviral transfection of the bone marrow pre-
immunodeficiency, who lack the gc component of the cursors. The rearrangement of the m gene in this study
IL-7 receptor, were found to execute TCRb D±J, but not was evaluated indirectly, by expression of intracellular
V±DJ, rearrangements in thymocytes (Sleasman et al., m protein; however, the conclusions have been verified
1994). On the other hand, mouse fetal liver cells cultured at the DNAlevel (A. Venkitaraman, personal communica-
in IL-7 contained D-J, but not V-DJ rearrangements of tion). The retroviral approach permitted mutagenesis
the b locus (Tsuda et al., 1996). None of these studies and domain-swapping of the IL-7Ra construct to deter-
demonstrating a role for IL-7 in b locus rearrangement mine which components of this protein were required
distinguishes trophic from mechanistic activities. for B cell development. Swapping the intracellular do-
A mechanistic role in b locus rearrangement is main of IL-7Ra with that of IL-2Rb resulted in the same
supported by recent studies introducing transgenic ex- degree of survival and growth; however, rearrangement
pression of rearranged TCRa and TCRb genes into IL- of the IgH locus did not occur. Moreover, mutating a
7Ra2/2 mice (Crompton et al., 1997). This resulted in site on IL-7Ra (shown to regulate phosphatidylino-
the development of double-positive and single-positive sitol-3-kinase) eliminated expansion, but retained re-
thymocytes and peripheral T cells, implying that gene arrangement induction. Hence, the activities of IL-7Ra
rearrangement was the sole impediment to their matura- on IgH gene rearrangement are clearly separable from
tion in IL-7Ra2/2 mice. Since the numbers of thymocytes its trophic functions. It should be noted that IL-7Ra mice
remained reduced in these transgenic mice, it suggests accumulate some B cells, so the mechanistic require-
that, in addition to its gene rearrangement effect, a tro- ment is not absolute. Thus, the IgH locus resembles the
phic effect of IL-7Ra also occurs in ab T cell develop- TCRb locus in that significant rearrangements eventu-
ment. The same study concluded that TCRa locus re- ally accumulate, presumably at a much slower rate than
arrangement occurred independently of IL-7Ra signals. normal.
TCRg Locus
It was observed that mouse fetal liver cells, following
culture in IL-7, expressed mRNA from rearranged g loci Mechanism of IL-7Ra Effects on VDJ Recombination
Having discussed the anti-apoptotic activities of IL-7R,(Appasamy et al., 1993). This might have been due to
outgrowth of previously rearranged cells, or, as was we now consider its mechanistic effects on VDJ recom-
bination. Mechanistic effects are most clearly demon-proposed, induction by IL-7 of transcription from re-
arranged loci. However, recent studies clearly implicate strated for the TCRb, g, and IgH loci. The same mecha-
nistic principles may apply to the TCRd locus, or,IL-7Ra signals in rearrangement of the g locus. IL-7Ra2/2
mice showed a severe impairment in g rearrangement alternatively, its IL-7Ra dependency may be purely
trophic.(Maki et al., 1996a). We also observed this impaired g
locus rearrangement in an independently derived IL- One mechanistic effect may be through induction of
the recombinase components. IL-7 sustained the ex-7Ra2/2 mouse strain (CandeÂ ias et al., 1997). In both
studies, the b and d loci had normal rearrangement pat- pression of RAG-1 and RAG-2 in thymocytes in culture
(Muegge et al., 1993), and induced them (together withterns. This finding demonstrates a mechanistic role for
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a signal from stromal cells) in a lymphoid progenitor cell some IL-7 signals (Danial et al., 1995). Are the oncogenic
effects of IL-7 and v-Abl a result of anti-apoptosis, orline (Tagoh et al., 1996). IL-7Ra2/2 mice had greatly
reduced RAG expression in double-negative cells overstimulation of VDJ recombination?
(Crompton et al., 1997); however, in the double-positive
cells that sometimes develop in these mice, normal RAG Future Studies
expression was observed, leading to the suggestion that Great strides are being made in understanding how the
IL-7Ra signals are required for RAG expression in dou- VDJ recombinase complex interacts with artificial sub-
ble-negative but not double-positive cells. strates, but little is understood of how natural substrates
Another potential action of IL-7Ra is on locus accessi- rearrange in a chromatin context. Regulation of D-, J-,
bility in both T and B cells, and one mechanism could and C-region transcripts prior to rearrangement, methyl-
take place through enhancers, whose importance in re- ation, DNAse hypersensitivity, footprinting, and other
arrangement is discussed above. If a general role of studies of the endogenous genes will help identify how
IL-7Ra in V(D)J rearrangements is through enhancing these loci respond to exogenous stimuli such as IL-7.
locus accessibility, the requirement for it is most strin- Suitable cell lines would greatly promote the study of
gent for the TCRg locus, suggesting that alternative sig- rearrangement of endogenous genes in response to ex-
nals, albeit less effective, can operate on the other loci. ogenous signals. Studies are currently being conducted
The TCRg locus contains enhancers 39 of Cg1, Cg2, and on transgenic mice that have been constructed todistin-
Cg3 genes (Spencer et al., 1991; Vernooij et al., 1991), guish trophic from mechanistic requirements of IL-7Ra
and the binding proteins have been partly defined (Hsi- in VDJ recombinationÐfor example, in studies of antia-
ang et al., 1995). Cytokine signals have been shown to poptotic transgenes versus rearranged TCR genes re-
induce c-region transcripts from g genes in thymocytes constituting IL-7Ra2/2 mice (such as shown for TCRab
(Gotlieb et al., 1993). STAT5 has been implicated in the genes, Crompton et al., 1997). The RAG gene regulatory
activation of unrearranged g transcripts in myeloid cells regions can be examined. The parts of IL-7Ra that medi-
(Quelle et al., 1996); in this cell type this probably occurs ate different signals can be tested by ªknockinº experi-
through induction of a secondary messenger (Weinstein ments. Distinction of the antiapoptotic from the possible
et al., 1989). However, there are also STAT5-binding growth actions of IL-7Ra needs to be approached by
motifs (Ihle, 1996) in the g enhancer sequences, so determining whether its intracellular targets include reg-
STAT5 could also act directly. IL-7 has been shown to ulators of cell cycle as well as cell death.
activate STAT5 (Foxwell et al., 1995). Thus, IL-7R may
signal the g enhancers, which in turn render the genes Conclusions
accessible to the VDJ recombinase. There is also a si- IL-7Ra clearly delivers trophic signals to immature lym-
lencer invoked in g mRNA expression (Ishida et al., 1990; phocytes during VDJ recombination. However, its role
Sim et al., 1995) which could be released in response in g gene rearrangement is mechanistic, as shown by
to stimulation with IL-7. the lack of rearrangements in IL-7Ra2/2 mice. IL-7Ra
If IL-7Ra has a general locus access effect in both T also has mechanistic roles in IgH and TCRb re-
and B cells, there must be additional regulators, in addi- arrangements (although the requirement is not absolute)
tion to IL-7, that establish the different panel of genes as shown by mutations of IL-7Ra that distinguish trophic
rearranged in T versus B cells, and the order of re- from mechanistic effects in IgH rearrangement and by
arrangements (D-J preceding V-D). introduction of rearranged ab transgenes that bypass
The rearranging loci may not be the only genes ren- the IL-7Ra requirement in T cell development. For the
dered accessible by IL-7Ra signals. There is some evi- TCRd locus, it is unclearas yetwhether there isa mecha-
dence that thymocytes developing in the absence of nistic role in addition to the trophic ones. TCRa locus
these signals do not, even after leaving the thymus, rearrangement is independent of IL-7Ra signals.
express a normal gene program. It has been noted that
most of the peripheral T cells that accumulate in IL- Acknowledgments
7Ra2/2 mice undergo apoptosis, rather than proliferate,
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